BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18929495)

  • 1. O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity.
    Issad T; Kuo M
    Trends Endocrinol Metab; 2008 Dec; 19(10):380-9. PubMed ID: 18929495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAc modification, insulin signaling and diabetic complications.
    Issad T; Masson E; Pagesy P
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [O-GlcNAc glycosylation and regulation of cell signaling].
    Issad T
    Med Sci (Paris); 2010; 26(8-9):753-9. PubMed ID: 20819714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks.
    Slawson C; Housley MP; Hart GW
    J Cell Biochem; 2006 Jan; 97(1):71-83. PubMed ID: 16237703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-translational modification by O-GlcNAc: another way to change protein function.
    Kudlow JE
    J Cell Biochem; 2006 Aug; 98(5):1062-75. PubMed ID: 16598783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
    Dauphinee SM; Ma M; Too CK
    J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability.
    Yang X; Su K; Roos MD; Chang Q; Paterson AJ; Kudlow JE
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6611-6. PubMed ID: 11371615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin.
    Walgren JL; Vincent TS; Schey KL; Buse MG
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E424-34. PubMed ID: 12397027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAc modification of FoxO1 increases its transcriptional activity: a role in the glucotoxicity phenomenon?
    Kuo M; Zilberfarb V; Gangneux N; Christeff N; Issad T
    Biochimie; 2008 May; 90(5):679-85. PubMed ID: 18359296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc inhibits interaction between Sp1 and sterol regulatory element binding protein 2.
    Lim K; Chang HI
    Biochem Biophys Res Commun; 2010 Mar; 393(2):314-8. PubMed ID: 20138838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAc inhibits interaction between Sp1 and Elf-1 transcription factors.
    Lim K; Chang HI
    Biochem Biophys Res Commun; 2009 Mar; 380(3):569-74. PubMed ID: 19285002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of O-GlcNAcylation.
    Hurtado-Guerrero R; Dorfmueller HC; van Aalten DM
    Curr Opin Struct Biol; 2008 Oct; 18(5):551-7. PubMed ID: 18822376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of O-GlcNAc glycosylation during Xenopus oocyte maturation.
    Lefebvre T; Baert F; Bodart JF; Flament S; Michalski JC; Vilain JP
    J Cell Biochem; 2004 Nov; 93(5):999-1010. PubMed ID: 15389870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells.
    Kang ES; Han D; Park J; Kwak TK; Oh MA; Lee SA; Choi S; Park ZY; Kim Y; Lee JW
    Exp Cell Res; 2008 Jul; 314(11-12):2238-48. PubMed ID: 18570920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of topoisomerase I activity by glucose and by O-GlcNAcylation of the enzyme protein.
    Noach N; Segev Y; Levi I; Segal S; Priel E
    Glycobiology; 2007 Dec; 17(12):1357-64. PubMed ID: 17932134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of O-linked beta-N-acetylglucosamine modification sites in key contractile proteins of rat skeletal muscle.
    Hédou J; Bastide B; Page A; Michalski JC; Morelle W
    Proteomics; 2009 Apr; 9(8):2139-48. PubMed ID: 19322778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of O-GlcNAcylation in nutritional sensing, insulin resistance and in mediating the benefits of exercise.
    Myslicki JP; Belke DD; Shearer J
    Appl Physiol Nutr Metab; 2014 Nov; 39(11):1205-13. PubMed ID: 25203141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global identification of O-GlcNAc-modified proteins.
    Nandi A; Sprung R; Barma DK; Zhao Y; Kim SC; Falck JR; Zhao Y
    Anal Chem; 2006 Jan; 78(2):452-8. PubMed ID: 16408927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-linked N-acetylglucosamine suppresses thermal aggregation of Sp1.
    Lim KH; Chang HI
    FEBS Lett; 2006 Aug; 580(19):4645-52. PubMed ID: 16879824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1.
    Lim K; Chang HI
    FEBS Lett; 2009 Feb; 583(3):512-20. PubMed ID: 19070619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.